Scar Channels in Cardiac Magnetic Resonance to Predict Appropriate Therapies in Primary Prevention
Overview
Authors
Affiliations
Background: Scar characteristics analyzed by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) are related with ventricular arrhythmias. Current guidelines are based only on the left ventricular ejection fraction to recommend an implantable cardioverter-defibrillator (ICD) in primary prevention.
Objectives: Our study aims to analyze the role of imaging to stratify arrhythmogenic risk in patients with ICD for primary prevention.
Methods: From 2006 to 2017, we included 200 patients with LGE-CMR before ICD implantation for primary prevention. The scar, border zone, core, and conducting channels (CCs) were automatically measured by a dedicated software.
Results: The mean age was 60.9 ± 10.9 years; 81.5% (163) were men; 52% (104) had ischemic cardiomyopathy. The mean left ventricular ejection fraction was 29% ± 10.1%. After a follow-up of 4.6 ± 2 years, 46 patients (22%) reached the primary end point (appropriate ICD therapy). Scar mass (36.2 ± 19 g vs 21.7 ± 10 g; P < .001), border zone mass (26.4 ± 12.5 g vs 16.0 ± 9.5 g; P < .001), core mass (9.9 ± 8.6 g vs 5.5 ± 5.7 g; P < .001), and CC mass (3.0 ± 2.6 g vs 1.6 ± 2.3 g; P < .001) were associated with appropriate therapies. Scar mass > 10 g (25.31% vs 5.26%; hazard ratio 4.74; P = .034) and the presence of CCs (34.75% vs 8.93%; hazard ratio 4.07; P = .003) were also strongly associated with the primary end point. However, patients without channels and with scar mass < 10 g had a very low rate of appropriate therapies (2.8%).
Conclusion: Scar characteristics analyzed by LGE-CMR are strong predictors of appropriate therapies in patients with ICD in primary prevention. The absence of channels and scar mass < 10 g can identify patients at a very low risk of ventricular arrhythmias in this population.
Prophylactic ICD Survival Benefit Prediction: Review and Comparison between Main Scores.
Rav-Acha M, Dadon Z, Wolak A, Hasin T, Goldenberg I, Glikson M J Clin Med. 2024; 13(17).
PMID: 39274520 PMC: 11396278. DOI: 10.3390/jcm13175307.
Hammersley D, Zegard A, Androulakis E, Jones R, Okafor O, Hatipoglu S J Am Coll Cardiol. 2024; 84(15):1407-1420.
PMID: 39217566 PMC: 11444937. DOI: 10.1016/j.jacc.2024.06.046.
Alfieri M, Guerra F, Lofiego C, Fogante M, Ciliberti G, Vagnarelli F Medicina (Kaunas). 2024; 60(4).
PMID: 38674259 PMC: 11051713. DOI: 10.3390/medicina60040613.
Bhagirath P, Campos F, Zaidi H, Chen Z, Elliott M, Gould J Heart Rhythm. 2024; 21(10):1962-1969.
PMID: 38670247 PMC: 11739773. DOI: 10.1016/j.hrthm.2024.04.077.
Masszi R, Zsigmond E, Ehrenberger R, Turan C, Fehervari P, Teutsch B Clin Res Cardiol. 2024; .
PMID: 38587562 DOI: 10.1007/s00392-024-02441-2.